Global trade agreements threaten access to affordable medicines in developing countries.
The article discusses how patents in trade agreements have affected the global pharmaceutical industry. It explains how these agreements have led to more pharmaceutical patents worldwide and introduces new rules that go beyond existing agreements. These new rules may pose challenges for developing countries. The timing of when countries started allowing drug patents affects how these rules impact drug prices and access.